Aug 30, 2020 / 11:30PM GMT
Operator
Thank you for standing by, and welcome to the Nova Eye Medical FY '20 Investor Conference Call. (Operator Instructions)
I would now like to hand the conference over to Tom Spurling, Director of the company. Please go ahead.
Thomas H. Spurling - Nova Eye Medical Limited - Consultant & Director
Thank you. Good morning, everyone. Thanks for taking the time to listen to our story. As the introduction, I'm pleased to be appointed this morning as a Director of Nova Eye and Victor Previn is with me. I will lead the discussion, but please feel free to ask questions at the end for both me or Victor.
If we could just kick off on Page 3. Obviously, the divestment of our Capital Equipment business for $100 million was a big focus over the last 12 months. And we now have a company that can focus on the fastest-growing segment of the ophthalmic market that is consumable surgical devices for glaucoma disease management. That is our primary focus. On the 31st of July or 2nd of July, we announced at 31st of July, we completed the acquisition of Molteno, a
Full Year 2020 Nova Eye Medical Ltd Earnings Call Transcript
Aug 31, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers